We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Bupivacaine Injection BP, bupivacaine hydrochloride 0.25% (50mg/20mL) single use vials
Section 19A approved medicine
(Approval lapsed) Bupivacaine Injection BP, bupivacaine hydrochloride 0.25% (50mg/20mL) single use vials
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
MARCAIN 0.25% bupivacaine hydrochloride (as monohydrate) 50mg/20mL injection ampoule - ARTG 48380
Indication(s)
Adults (> 18 years of age):
BUPIVACAINE INJECTION BP (bupivacaine hydrochloride) is indicated for:
- Local infiltration
- Peripheral minor or major nerve blocks
- Epidural block for surgery
- Epidural block by continuous infusion or intermittent bolus for postoperative or labour pain relief
Standard procedures for local infiltration, minor and major nerve blocks, retrobulbar block or epidural block should be observed.
Geriatrics (> 65 years of age):
Elderly patients should be given reduced doses commensurate with their age and physical condition.
Pediatrics (< 2 years of age):
Until further experience is gained in children younger than two years, administration of any presentation of bupivacaine injection in this age group is not recommended.